As mentioned on our Health Industry Washington Watch blog, the FDA will host a public workshop on April 1, 2015 to provide updates on the use of clinical outcome assessments (COAs), as well as to address plans for future development and use of COAs in drug development programs. The workshop, entitled “Clinical Outcomes Assessment Development … Continue Reading
As highlighted on our Health Industry Washington Watch blog, Reed Smith hosted a dynamic conference on post-acute care in Washington, D.C. in early April. Entitled “Reed Smith 2014 Washington Health Care Conference: Focus on Post-Acute Care,” the conference brought together a panel of experts discussing episodic care, proposed bundling models, and alternative payment and delivery systems; … Continue Reading
On April 4th, 2014, Reed Smith will host its inaugural Washington Health Care Conference at The Mayflower Renaissance Hotel in Washington, D.C. With a keynote from Dr. Norman Ornstein, this year's conference will focus on post-acute care, bringing together leading industry professionals for a discussion on several important issues. Limited seating is still available for this complimentary program. If you are interested in registering, please email Lindsay Korenich at lkorenich@reedsmith.com.… Continue Reading
Next week, Reed Smith will host a conference on “Big Data Monetization” at the Quadrus Conference Center in Silicon Valley (8:30-11:30 a.m. PDT). Big Data is a term used to characterize the accumulation of data. Virtually every company, in every industry, is now an information and technology company. Companies run on Big Data, whether it … Continue Reading
The American Health Lawyers Association's Annual Meeting will be held June 26-29, 2011, in Boston. This year's program will deliver insights from leading practitioners, in-house counsel and government representatives on the latest developments and trends concerning transactions, reimbursement, tax, privacy and security, antitrust, fraud and abuse enforcement, and accountable care organizations, among other key topics.… Continue Reading
The Food and Drug Law Institute (FDLI) has an interesting upcoming conference on June 13-14 in Beijing, China that will address current legal, regulatory and economic issues regarding food, cosmetics, dietary supplements, pharmaceuticals and medical devices in China and the United States. Speakers are top government officials and internationally renowned experts who will discuss the issues in both countries.… Continue Reading
Today the FDA published a notice announcing public hearings on November 2 and 3, 2010 on implementation of the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which was enacted as part of the Affordable Care Act (ACA). The BPCI Act establishes an abbreviated approval pathway for biological products that are demonstrated to be … Continue Reading
